fenofibrate has been researched along with Leukostasis in 4 studies
Pharmavit: a polyvitamin product, comprising vitamins A, D2, B1, B2, B6, C, E, nicotinamide, & calcium pantothene; may be a promising agent for application to human populations exposed to carcinogenic and genetic hazards of ionizing radiation; RN from CHEMLINE
Leukostasis: Abnormal intravascular leukocyte aggregation and clumping often seen in leukemia patients. The brain and lungs are the two most commonly affected organs. This acute syndrome requires aggressive cytoreductive modalities including chemotherapy and/or leukophoresis. It is differentiated from LEUKEMIC INFILTRATION which is a neoplastic process where leukemic cells invade organs.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Fenofibrate is a peroxisome proliferator-activated receptor α (PPARα) agonist and has been shown to have therapeutic effects on diabetic retinopathy (DR)." | 7.91 | Fenofibrate-Loaded Biodegradable Nanoparticles for the Treatment of Experimental Diabetic Retinopathy and Neovascular Age-Related Macular Degeneration. ( Chen, Q; Deng, G; Du, Y; Ma, JX; Ma, X; Matlock, G; Meng, T; Qiu, F; Shao, Y; Wang, X; Wu, W; Xu, Q; Zhou, K, 2019) |
| "Fenofibrate was given to mice in rodent chow." | 5.48 | Fenofibrate ameliorates diabetic retinopathy by modulating Nrf2 signaling and NLRP3 inflammasome activation. ( Cheng, R; Li, J; Liu, Q; Ma, JX; Yi, J; Zhang, F; Zhang, X, 2018) |
| "Fenofibrate is a peroxisome proliferator-activated receptor α (PPARα) agonist and has been shown to have therapeutic effects on diabetic retinopathy (DR)." | 3.91 | Fenofibrate-Loaded Biodegradable Nanoparticles for the Treatment of Experimental Diabetic Retinopathy and Neovascular Age-Related Macular Degeneration. ( Chen, Q; Deng, G; Du, Y; Ma, JX; Ma, X; Matlock, G; Meng, T; Qiu, F; Shao, Y; Wang, X; Wu, W; Xu, Q; Zhou, K, 2019) |
| "Fenofibrate was given to mice in rodent chow." | 1.48 | Fenofibrate ameliorates diabetic retinopathy by modulating Nrf2 signaling and NLRP3 inflammasome activation. ( Cheng, R; Li, J; Liu, Q; Ma, JX; Yi, J; Zhang, F; Zhang, X, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Qiu, F | 2 |
| Matlock, G | 2 |
| Chen, Q | 2 |
| Zhou, K | 2 |
| Du, Y | 2 |
| Wang, X | 2 |
| Ma, JX | 3 |
| Liu, Q | 1 |
| Zhang, F | 1 |
| Zhang, X | 1 |
| Cheng, R | 1 |
| Yi, J | 1 |
| Li, J | 1 |
| Meng, T | 1 |
| Shao, Y | 1 |
| Ma, X | 1 |
| Wu, W | 1 |
| Deng, G | 1 |
| Xu, Q | 1 |
| Shen, W | 1 |
| Gao, Y | 1 |
| Lu, B | 1 |
| Zhang, Q | 1 |
| Hu, Y | 1 |
| Chen, Y | 1 |
4 other studies available for fenofibrate and Leukostasis
| Article | Year |
|---|---|
Therapeutic Effects of PPARα Agonist on Ocular Neovascularization in Models Recapitulating Neovascular Age-Related Macular Degeneration.
Topics: Animals; Blotting, Western; Capillary Permeability; Choroidal Neovascularization; Disease Models, An | 2017 |
Fenofibrate ameliorates diabetic retinopathy by modulating Nrf2 signaling and NLRP3 inflammasome activation.
Topics: Animals; Capillary Permeability; Caspase 1; Diabetes Mellitus, Experimental; Diabetic Retinopathy; F | 2018 |
Fenofibrate-Loaded Biodegradable Nanoparticles for the Treatment of Experimental Diabetic Retinopathy and Neovascular Age-Related Macular Degeneration.
Topics: Animals; Capillary Permeability; Choroidal Neovascularization; Diabetes Mellitus, Experimental; Diab | 2019 |
Negatively regulating TLR4/NF-κB signaling via PPARα in endotoxin-induced uveitis.
Topics: Animals; Cytokines; Endotoxins; Fenofibrate; Leukostasis; Lipopolysaccharides; Male; NF-kappa B; PPA | 2014 |